Resources

Awareness of Nucleic Acid-Based Therapies

In this Syndicated Report we had two goals:

  • Provide a baseline understanding of current knowledge among physicians regarding the types of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
  • Serve as a vehicle for future surveys to assess how knowledge and perceptions change over time.

Methodology: 12-Minute MicroSurvey
Crowds: PCPs, Oncologists, & Pediatricians
Sample Size: n=250
Fielding Period:
September 8-10, 2019

This report explores physician awareness of the following RNA- or DNA-based therapeutic methods:

  • RNAi (RNA interference)
  • siRNA (short interfering RNAs)
  • ASO (antisense oligonucleotides)
  • mRNA (messenger ribonucleic acid)
  • AAV (adeno-associated virus)
  • CRISPR (clustered regularly interspaced short palindromic repeats)
  • TALENs (transcription activator-like effector nuclease)

Download the report now!

Please fill out the form below to access this content

Name(Required)
Consent
This field is for validation purposes and should be left unchanged.

Related Resources

The Impact of Technology on Mental Healthcare

The Impact of Technology on Mental Healthcare

Exploring Psychiatrist Opinions and Expectations Around the Rise in Digital Therapeutics to Treat Mental Health The National Institutes of Health (NIH) believe “technology has opened a new frontier in mental health support,” but questions remain around how...

read more
ESMO 2022 Real-Time Roundup

ESMO 2022 Real-Time Roundup

The 2022 Annual Meeting of the European Society for Medical Oncology (ESMO) took place in person from September 9th to the 13th. InCrowd wanted to learn from those Medical Oncologists and Hematology-Oncologists who attended the following two objectives: Explore which...

read more
ASCO 2022 Real-Time Roundup

ASCO 2022 Real-Time Roundup

The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) took place in person from June 3rd to the 7th. InCrowd wanted to learn from those oncologists who attended the following two objectives: Explore which tumor type/track had the most exciting...

read more